Related Experiment Video
Updated: Feb 13, 2026

Biotin-based Pulldown Assay to Validate mRNA Targets of Cellular miRNAs
Published on: June 12, 2018
Targeting mRNA Decapping in AML
Akihide Yoshimi1, Omar Abdel-Wahab2
1Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA.
Abstract:
In this issue of Cancer Cell, Yamauchi et al. identify a dependency of acute myeloid leukemia (AML) on DCPS, which catalyzes the final step of 3'-to-5' mRNA decay and is implicated in numerous aspects of RNA metabolism. DCPS is targetable with a clinical inhibitor, underscoring the translational importance of this discovery.
Insights
Researchers discovered that acute myeloid leukemia (AML) depends on an enzyme called DCPS, which is crucial for RNA metabolism. This enzyme can be targeted with a drug, offering a potential new treatment strategy for AML patients.
Area of Science:
- Molecular Biology
- Cancer Research
- RNA Metabolism
Background:
- Acute myeloid leukemia (AML) is a complex hematological malignancy.
- RNA metabolism plays a critical role in cellular function and disease pathogenesis.
- The enzyme decapping enzyme (DCPS) is involved in messenger RNA (mRNA) degradation.
Purpose of the Study:
- To investigate the role of DCPS in acute myeloid leukemia.
- To determine if DCPS is a potential therapeutic target in AML.
Main Methods:
- Utilized molecular biology techniques to study DCPS function in AML cell lines.
- Employed a clinical inhibitor of DCPS to assess its efficacy in preclinical AML models.
Main Results:
- Identified a significant dependency of AML cells on DCPS activity.
- Demonstrated that inhibiting DCPS effectively reduces AML cell viability and proliferation.
- Confirmed that DCPS is a druggable target in AML.
Conclusions:
- DCPS is essential for the survival and proliferation of acute myeloid leukemia cells.
- Targeting DCPS with a clinical inhibitor presents a promising therapeutic strategy for AML.
- This discovery highlights the translational potential of targeting RNA metabolism in cancer therapy.
Related Concept Videos
mRNA Stability and Gene Expression
Cis-acting Elements involved in mRNA stability
Regulated mRNA Transport
Regulated mRNA Transport
pre-mRNA Processing
Once about 20-40 ribonucleotides have been joined together by RNA polymerase, a group of enzymes adds a “cap” to the 5’ end of the growing transcript. In this process, a 5’ phosphate is replaced by modified guanosine that has a methyl group attached to it (7-Methyl...
Nuclear Export of mRNA
Nuclear Export of mRNA

